IFP Advisors, Inc CRNX — CRINETICS PHARMACEUTICALS IN

Ownership history in IFP Advisors, Inc  ·  7 quarters on record

AI Ownership Summary

IFP Advisors, Inc reported CRINETICS PHARMACEUTICALS IN (CRNX) in 7 quarterly 13F filings from 2024 Q2 through 2026 Q1. The latest visible filing shows CRNX at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CRNX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was IFP Advisors, Inc's position in CRINETICS PHARMACEUTICALS IN, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CRNX was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CRNX stock page IFP Advisors, Inc fund profile IFP Advisors, Inc full holdings
How IFP Advisors, Inc held CRNX — position size vs. price
% of Fund (quarterly)    CRNX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED — — — 1,443 -3 -0.2% 0.00% $52K 2026-04-13 $38.66
2025 Q4 ADDED — — — 1,446 +99 +7.3% 0.00% $67K 2026-02-06 $45.28
2025 Q3 REDUCED — — — 1,347 -8 -0.6% 0.00% $64K 2025-12-02 $45.01
2025 Q2 REDUCED 6.0% +51.3% ❌ 1,355 -86 -6.0% 0.00% $44K 2025-07-24 $30.41
2025 Q1 ADDED — — — 1,441 +25 +1.8% 0.00% $49K 2025-05-05 $33.65
2024 Q4 REDUCED — — — 1,416 -74 -5.0% 0.00% $72K 2025-02-04 $40.40
2024 Q2 INITIATED — — — 1,490 — — 0.00% $70K 2024-07-30 $52.64

🏢 Other funds also holding CRNX

As of 2026 Q1 — sorted by position size

EcoR1 Capital, LLC 3Y 7Y 6.61% Novo Holdings A/S 3Y 7Y 4.56% First Light Asset Management, LLC 3Y 7Y 3.55% GordonMD Global Investments LP 3.21% Bellevue Group AG 3Y 7Y 2.84% Semanteon Capital Management, LP 2.71% ADAR1 Capital Management, LLC 2.44% Prosight Management, LP 3Y 7Y 2.08% Siren, L.L.C. 1.92% FARALLON CAPITAL MANAGEMENT LLC 3Y 7Y 1.73%

FAQ About IFP Advisors, Inc and CRNX

These are the practical questions this page is built to answer before you even open the full history table.

How long has IFP Advisors, Inc reported owning CRNX?

IFP Advisors, Inc reported CRNX across 7 quarterly 13F filings, from 2024 Q2 through 2026 Q1.

What was the largest reported CRNX position in IFP Advisors, Inc's portfolio?

The largest reported portfolio weight for CRNX was 0.00% in 2024 Q2.

What is the latest reported CRNX position on this page?

The most recent filing on this page is 2026 Q1, when IFP Advisors, Inc reported 1,443 shares, equal to 0.00% of portfolio, with an estimated market value of $52K.

What does the chart on this CRNX ownership page compare?

The chart compares IFP Advisors, Inc's quarterly CRNX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did IFP Advisors, Inc time their CRNX position?

Based on 13F filing dates vs. subsequent CRNX price moves, IFP Advisors, Inc correctly timed 1 out of 6 reported position changes (17%). The annualised alpha on CRNX relative to SPY over the holding period was -28.2%.

← Back to IFP Advisors, Inc Holdings